Abbisko Cayman Limited (HKG:2256)
Hong Kong · Delayed Price · Currency is HKD 14.28
+0.40 (2.88%)
Jan 21, 2026, 4:08 PM HKT
Abbisko Cayman Market Cap
Abbisko Cayman has a market cap or net worth of 9.33 billion as of January 21, 2026. Its market cap has increased by 234.65% in one year.
Market Cap
9.33B
Enterprise Value
6.86B
Revenue
678.11M
Ranking
n/a
PE Ratio
56.88
Stock Price
14.28
Market Cap Chart
Since October 15, 2021, Abbisko Cayman's market cap has increased from 8.71B to 9.33B, an increase of 7.14%. That is a compound annual growth rate of 1.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 9.33B | 6.69% |
| Dec 31, 2025 | 8.75B | 204.13% |
| Dec 31, 2024 | 2.88B | 21.63% |
| Dec 29, 2023 | 2.36B | 4.97% |
| Dec 30, 2022 | 2.25B | -64.77% |
| Dec 31, 2021 | 6.39B | -26.60% |
| Oct 15, 2021 | 8.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.88B |
| Hansoh Pharmaceutical Group Company | 260.32B |
| JD Health International | 215.66B |
| WuXi Biologics | 164.43B |
| Innovent Biologics | 155.25B |
| Sino Biopharmaceutical | 124.24B |
| CSPC Pharmaceutical Group | 112.39B |
| Akeso | 111.46B |